First Fantom Encore Implanted in the FANTOM Post Market Trial SAN DIEGO, Oct. 31, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX: RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback